ProCE Banner Activity

Biomarker-Driven Treatment of Advanced Gastrointestinal Malignancies

Slideset Download
Download these slides from our 2020 ASCO-GI live satellite symposium on biomarker-driven treatment of advanced gastrointestinal malignancies including colorectal cancer and pancreatic cancer.

Released: January 23, 2020

Expiration: January 21, 2021

No longer available for credit.

Share

Faculty

Pashtoon M. Kasi

Pashtoon M. Kasi, MD, MS

Director 
Colon Cancer Research 
Weill Cornell Medicine
Director 
Liquid Biopsy Research 
Englander Institute of Precision Medicine 
New York, New Yotk

Michael J. Pishvaian

Michael J. Pishvaian, MD, PhD

Associate Professor
Sidney Kimmel Cancer Center
Johns Hopkins University
Director
Clinical Research, GI and Phase I Oncology in the National Capital Region
Johns Hopkins at Sibley Memorial Cancer Center
Washington, DC

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Array BioPharma

Bayer Healthcare Pharma

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Pashtoon M. Kasi, MD, MS

Director 
Colon Cancer Research 
Weill Cornell Medicine
Director 
Liquid Biopsy Research 
Englander Institute of Precision Medicine 
New York, New Yotk

Pashtoon Kasi, MD, has disclosed that he has received consulting fees from Foundation Medicine, Ipsen, Natera, and Taiho and funds for research support from Amgen, Array, AstraZeneca, BTG, Clovis, and RenovoRx.

Michael J. Pishvaian, MD, PhD

Associate Professor
Sidney Kimmel Cancer Center
Johns Hopkins University
Director
Clinical Research, GI and Phase I Oncology in the National Capital Region
Johns Hopkins at Sibley Memorial Cancer Center
Washington, DC

Michael J. Pishvaian, MD, PhD, has disclosed that he has received consulting fees from AstraZeneca/MedImmune, Halozyme, Merck, and Perthera; has ownership interest in Perthera; has intellectual property rights from AbbVie; has received fees for non-CME/CE services from Sirtex; and has received funds for research support paid to his institution from Armo BioSciences, Bavarian Nordic, Bayer, Bristol-Myers Squibb, Calithera, Celgene, Celldex, Curegenix, FibroGen, Genentech, Gilead Sciences, GlaxoSmithKline, Halozyme, Karyopharm, MedImmune, Merck, Novartis, Regeneron, Pfizer, Pharmacyclics, and Tesaro.